Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic

MLA

Tabish Rehman, et al. “Screening Marine Algae Metabolites as High-Affinity Inhibitors of SARS-CoV-2 Main Protease (3CLpro): An in Silico Analysis to Identify Novel Drug Candidates to Combat COVID-19 Pandemic.” Applied Biological Chemistry, vol. 63, no. 1, Nov. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e20a7b207f59c9243b16316747a2d9a3&authtype=sso&custid=ns315887.

APA

Tabish Rehman, M. Zuhaib Qayyum, Adil Alshoaibi, Ghazala Muteeb, & Mohammad Aatif. (2020). Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic. Applied Biological Chemistry, 63(1).

Chicago

Tabish Rehman, M. Zuhaib Qayyum, Adil Alshoaibi, Ghazala Muteeb, and Mohammad Aatif. 2020. “Screening Marine Algae Metabolites as High-Affinity Inhibitors of SARS-CoV-2 Main Protease (3CLpro): An in Silico Analysis to Identify Novel Drug Candidates to Combat COVID-19 Pandemic.” Applied Biological Chemistry 63 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e20a7b207f59c9243b16316747a2d9a3&authtype=sso&custid=ns315887.